The Role of Bridging Therapy in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver accounting for 7% of all cancers worldwide. Most cases of HCC develop within an established background of chronic liver disease. For that reason, liver resection is only possible in selected patients. Liver transplanta...
Saved in:
Main Authors: | Roberto Galuppo, Angie McCall, Roberto Gedaly |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2013-01-01
|
Series: | International Journal of Hepatology |
Online Access: | http://dx.doi.org/10.1155/2013/419302 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of inflammasomes in hepatocellular carcinoma: Mechanisms and therapeutic insights
by: Valentina Arrè, et al.
Published: (2025-01-01) -
Targeted Therapy in Hepatocellular Carcinoma
by: Clarinda W. L. Chua, et al.
Published: (2011-01-01) -
Diagnosis, Therapy, and Prognosis for Hepatocellular Carcinoma
by: Zhigang Ren, et al.
Published: (2020-01-01) -
Emerging nanomedicine strategies for hepatocellular carcinoma therapy
by: Chen Guo, et al.
Published: (2024-09-01) -
Dramatic Reduction in Tumour Size in Hepatocellular Carcinoma Patients on Thalidomide Therapy
by: Denny Demeria, et al.
Published: (2007-01-01)